A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists
- 10 February 2012
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 27 (1), e131-e135
- https://doi.org/10.1111/j.1468-3083.2012.04456.x
Abstract
Background Adult pityriasis rubra pilaris (PRP) type 1 is a rare chronic papulosquamous disorder with clinical and histological parallels with psoriasis. Treatment is challenging and recent case reports suggest a potential role for tumour necrosis factor (TNF) antagonists. Objectives Our objective was to systematically review the literature for evidence of efficacy of TNF antagonists in the treatment of adult PRP. Methods We performed a systematic search of the Cochrane library, EMBASE, Pubmed and MEDLINE databases. We defined diagnosis of PRP, classified clinical response and whether this was clearly attributed to TNF-antagonists. We also reviewed disease, treatment duration and follow up. Results Sixteen articles were selected for detailed review. From these, 12 articles (13 cases) met our predefined criteria and were included in the systematic review. The authors identified two more cases from their personal archive. A total of 15 evaluable cases were included for analysis. Twelve showed complete response (CR) (80%) to TNF-antagonists with a mean time to maximal response of 5 months. In 10 of the CR cases (83%) this was clearly attributable to TNF antagonist therapy. Conclusion These data indicate that TNF-antagonists may be of value in treating adult type 1 PRP refractory to other systemic agents but selective reporting bias, together with the lack of standard diagnostic criteria and established spontaneous resolution in PRP, prevent any firm recommendations on their place in management.This publication has 18 references indexed in Scilit:
- Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazidClinical and Experimental Dermatology, 2011
- THERAPEUTIC HOTLINE: Treatment of pityriasis rubra pilaris with etanerceptDermatologic Therapy, 2011
- Pityriasis rubra pilaris successfully treated with adalimumabClinical and Experimental Dermatology, 2010
- Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatmentClinical and Experimental Dermatology, 2010
- Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexateJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Pityriasis rubra pilaris type 1 spontaneously resolving after 20 yearsClinical and Experimental Dermatology, 2009
- Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: Case report and review of the literature on biologic therapyJournal of the American Academy of Dermatology, 2008
- Successful use of etanercept in type I pityriasis rubra pilarisBritish Journal of Dermatology, 2007
- Pilyriasis rubry pilaris and human immunodeficiency virus infection-type 6 pityriasis rubra pilaris?British Journal of Dermatology, 1996
- Histologic Criteria for the Diagnosis of Pityriasis Rubra PilarisThe American Journal of Dermatopathology, 1986